Literature DB >> 9858915

Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil.

S Kuriyama1, K Masui, T Sakamoto, T Nakatani, M Kikukawa, H Tsujinoue, A Mitoro, M Yamazaki, H Yoshiji, H Fukui, K Ikenaka, C A Mullen, T Tsujii.   

Abstract

Because it appears impossible to transfer toxic genes to all the cells of a cancer, the bystander effect is critical to induce effective antitumor effects. In the present study, possible in vitro mechanisms of the bystander effect by the cytosine deaminase (CD) gene and 5-fluorocytosine (5-FC) were investigated. CD-transduced cancer cells exhibited much higher sensitivity to 5-FC compared to parental cells. CD-transduced cells caused killing of neighboring parental cells in the presence of 5-FC, irrespective of direct cell-to-cell contact. Media conditioned by CD-transduced cells and 5-FC contained considerable amounts of 5-fluorouracil (5-FU) and exhibited profound cytotoxicity on parental cells. Furthermore, this killing ability of conditioned media correlated well with 5-FU levels converted from 5-FC by CD-transduced cells. CD was shown not to be secreted into media from cells. These results indicate that diffusible 5-FU plays the substantially causative role in the in vitro bystander effect caused by the CD/5-FC system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9858915

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  18 in total

Review 1.  Progress and problems with the use of suicide genes for targeted cancer therapy.

Authors:  Zahra Karjoo; Xuguang Chen; Arash Hatefi
Journal:  Adv Drug Deliv Rev       Date:  2015-05-22       Impact factor: 15.470

2.  Overexpression of caveolin-1 in inflammatory breast cancer cells enables IBC-specific gene delivery and prodrug conversion using histone-targeted polyplexes.

Authors:  Nikki L Ross; Millicent O Sullivan
Journal:  Biotechnol Bioeng       Date:  2016-06-09       Impact factor: 4.530

3.  Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types.

Authors:  Chris G Twitty; Oscar R Diago; Daniel J Hogan; Cindy Burrascano; Carlos E Ibanez; Douglas J Jolly; Derek Ostertag
Journal:  Hum Gene Ther Methods       Date:  2015-12-01       Impact factor: 2.396

Review 4.  Chapter seven--Cancer treatment with gene therapy and radiation therapy.

Authors:  Sergey A Kaliberov; Donald J Buchsbaum
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

5.  Electrochemotherapy for colorectal cancer with commonly used chemotherapeutic agents in a mouse model.

Authors:  S Kuriyama; M Matsumoto; A Mitoro; H Tsujinoue; T Nakatani; H Fukui; T Tsujii
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

6.  Suicide gene approach using a dual-expression lentiviral vector to enhance the safety of ex vivo gene therapy for bone repair.

Authors:  F Alaee; O Sugiyama; M S Virk; H Tang; H Drissi; A C Lichtler; J R Lieberman
Journal:  Gene Ther       Date:  2013-11-28       Impact factor: 5.250

7.  Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine.

Authors:  Tiffany S Stolworthy; Aaron M Korkegian; Candice L Willmon; Andressa Ardiani; Jennifer Cundiff; Barry L Stoddard; Margaret E Black
Journal:  J Mol Biol       Date:  2008-01-11       Impact factor: 5.469

8.  Bacterial cytosine deaminase mutants created by molecular engineering show improved 5-fluorocytosine-mediated cell killing in vitro and in vivo.

Authors:  Michi Fuchita; Andressa Ardiani; Lei Zhao; Kinta Serve; Barry L Stoddard; Margaret E Black
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

9.  Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma.

Authors:  Timothy F Cloughesy; Joseph Landolfi; Daniel J Hogan; Stephen Bloomfield; Bob Carter; Clark C Chen; J Bradley Elder; Steven N Kalkanis; Santosh Kesari; Albert Lai; Ian Y Lee; Linda M Liau; Tom Mikkelsen; Phioanh Leia Nghiemphu; David Piccioni; Tobias Walbert; Alice Chu; Asha Das; Oscar R Diago; Dawn Gammon; Harry E Gruber; Michelle Hanna; Douglas J Jolly; Noriyuki Kasahara; David McCarthy; Leah Mitchell; Derek Ostertag; Joan M Robbins; Maria Rodriguez-Aguirre; Michael A Vogelbaum
Journal:  Sci Transl Med       Date:  2016-06-01       Impact factor: 17.956

10.  Exploiting cis-acting replication elements to direct hepatitis C virus-dependent transgene expression.

Authors:  Jing Zhang; Osamu Yamada; Takashi Sakamoto; Hiroshi Yoshida; Hiromasa Araki; Kunitada Shimotohno
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.